TrialJournal for immunotherapy of cancer2020

Safety and immunogenicity of novel 5T4 viral vectored vaccination regimens in early stage prostate cancer: a phase I clinical trial.

Federica Cappuccini et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.